Not applicableStudy completedNCT01825317What this trial is testingEffect of NeuroAD on Alzheimer PatientsWho this might be right forAlzheimer's Disease Neuronix Ltd 32
Large-scale testing (Phase 3)Ended earlyNCT01969136What this trial is testingStudy of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseWho this might be right forAlzheimer's DiseaseDementia FORUM Pharmaceuticals Inc 403
Large-scale testing (Phase 3)Study completedNCT02585934What this trial is testingStudy Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET StudyWho this might be right forAlzheimer's Disease Axovant Sciences Ltd. 1,315
Not applicableNot Yet RecruitingNCT07673263What this trial is testingEffects of X Box Kinect 360 in Alzheimer's DiseaseWho this might be right forAlzheimer s Disease Ziauddin University 38
Early research (Phase 1)Ended earlyNCT02220738What this trial is testingStudy to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsWho this might be right forAlzheimer's Disease AbbVie 19
Testing effectiveness (Phase 2)Ended earlyNCT00334568What this trial is testingEffects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 12
Post-approval studies (Phase 4)Study completedNCT00230568What this trial is testingEARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)Who this might be right forAlzheimer's Disease Eisai Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00481520What this trial is testingStudy Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Wyeth is now a wholly owned subsidiary of Pfizer 72
Testing effectiveness (Phase 2)Ended earlyNCT00362024What this trial is testingMK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)Who this might be right forAlzheimer's Disease Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Looking for participantsNCT07058688What this trial is testingNTRX-07 in Participants With Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseMild Cognitive Impairment NeuroTherapia, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT00940589What this trial is testingEfficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE InhibitorWho this might be right forAlzheimer's DiseaseSleep Disorder Neurim Pharmaceuticals Ltd. 73
Testing effectiveness (Phase 2)UnknownNCT04388982What this trial is testingThe Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer Disease Ruijin Hospital 9
Large-scale testing (Phase 3)Ended earlyNCT05575076What this trial is testingOpen-label Extension for Phase 3 Clinical Trials of SimufilamWho this might be right forAlzheimer Disease Cassava Sciences, Inc. 1,081
Testing effectiveness (Phase 2)Ended earlyNCT05352763What this trial is testingOpen-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Cassava Sciences, Inc. 90
Not applicableStudy completedNCT05454540What this trial is testingRepetitive TMS of the Posterior DMN in ADWho this might be right forAlzheimer Disease I.R.C.C.S. Fondazione Santa Lucia 60
Large-scale testing (Phase 3)Looking for participantsNCT06976216What this trial is testingEvaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Bristol-Myers Squibb 586
Early research (Phase 1)Study completedNCT03522129What this trial is testingStudy to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Cognition Therapeutics 3
Post-approval studies (Phase 4)Study completedNCT01529619What this trial is testingEfficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase InhibitorsWho this might be right forAlzheimer's Disease Novartis Pharmaceuticals 52
Early research (Phase 1)Study completedNCT00757939What this trial is testingAssess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)Who this might be right forAlzheimer's Disease Merck Sharp & Dohme LLC 40
Large-scale testing (Phase 3)Study completedNCT00575055What this trial is testingBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)Who this might be right forAlzheimer's Disease JANSSEN Alzheimer Immunotherapy Research & Development, LLC 1,121